Mammalian adaptation risk in HPAI H5N8: a comprehensive model bridging experimental data with mathematical insights
Santosh Chokkakula(Chungbuk National University), Min‐Suk Song(Chungbuk National University), Yun Hee Baek(Chungbuk National University), Young Ki Choi(Institute for Basic Science), Ju Hwan Jeong(Chungbuk National University), Beom Kyu Kim(Chungbuk National University), Sol Oh(Chungbuk National University), Jihyun Park(Chungbuk National University), Wonsuk Choi(Chungbuk National University), Eung‐Gook Kim(Chungbuk National University), Chang Il Kim(Chungbuk National University), Seong Cheol Min(Chungbuk National University)
Cited by 4
Related Papers
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice
|Antiviral Research|2022|82
Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination Therapy
|Microorganisms|2023|77
SARS-CoV-2 drug resistance and therapeutic approaches
|Heliyon|2025|44
Small molecules that allosterically inhibit p21-activated kinase activity by binding to the regulatory p21-binding domain
|Experimental & Molecular Medicine|2016|28
Molecular surveillance of antimicrobial resistance and transmission pattern of <i>Mycobacterium leprae</i> in Chinese leprosy patients
|Emerging Microbes & Infections|2019|22